Determination of Post-COVID-19 Symptoms Among Recovered Cases in Iraqi Kurdistan Region: A CrossSectional Study
Keywords:
Covid-19, post-acute Covid-19, Disease Severity, Quality of life, Kurdistan region, IraqAbstract
Objective: The current study aimed to investigate post-Covid-19 symptoms and it is associated factors in Kurdistan region, Iraq. Methods: A cross-sectional study conducted among the general population. The study included 454 recovered COVID-19 patients; the questionnaire consists of four parts; starting from socio-demographic data, Items about the acute and post-COVID-19 status, and other comorbidities of the individuals. Quality of life was measured by EQ-5D Visual Analogue Scale and finally, WHO severity scales were used to assess Covid-19 conditions. Data were analyzed in the form of descriptive statistics and using SPSS version 24.0 (IBM Corp., Armonk, NY, USA). Results: The vast majority (75.6%) experienced post-symptoms for about 3 months or less. Post Covid-19 was found to be significantly (p < 0.05) related to gender, quality of life, and duration of symptoms. Common symptoms were fatigue 203 (44.7%), Myalgia 99 (21.8%), Sleep disturbance 84 (18.5%), Anosmia and Headache 65(14.3), and 64 (14.1) respectively. Nonetheless, we also observed a significant association between disease severity and the number of acute symptoms with post-COVID-19 symptoms. Conclusion: The bulk of the study's survivors reported experiencing post-COVID-19 symptoms. As a result, there is a critical requirement for evaluation and rehabilitation following the recovery, thus careful coordination between COVID-19 healthcare facilities and public hospitals is needed
Downloads
References
Karthik, L., Kumar, G., Keswani, T.,
Bhattacharyya, A., Chandar, S. S., &
Bhaskara Rao, K. V. (2014). Protease
inhibitors from marine actinobacteria as a
potential source for antimalarial
compound. PloS one, 9(3), e90972.
World Health Organization. (2020). Responding to
community spread of COVID-19: interim
guidance, 7 March 2020 (No. WHO/COVID-
/Community_Transmission/2020.1). World
Health Organization.
Coronavirus (COVID-19) dashboard:
Information and advice-GOV.KRD.
Available at https://gov.krd/coronavirusen/dashboard/.
Auzzir, Z. A., Haigh, R. P., & Amaratunga, D.
(2014). Public-private partnerships (PPP) in
disaster management in developing countries:
a conceptual framework. Procedia
economics and finance, 18, 807-814.
Chen YT, Shao SC, Hsu CK,Wu IW, Hung
MJ, Chen YC. Incidence of acute kidney
injury in COVID-19 infection: a
systematic review and meta-analysis. Crit
Care. (2020) 24:346. doi: 10.1186/s13054-
-03009-y.
Hui, D. S., Joynt, G. M., Wong, K. T.,
Gomersall, C. D., Li, T. S., Antonio, G.,
... & Sung, J. J. Y. (2005). Impact of severe
acute respiratory syndrome (SARS) on
pulmonary function, functional capacity
and quality of life in a cohort of
survivors. Thorax, 60(5), 401-409.
Ahmed, H., Patel, K., Greenwood, D. C., Halpin,
S., Lewthwaite, P., Salawu, A., ... & Sivan, M.
(2020). Long-term clinical outcomes in
survivors of severe acute respiratory syndrome
(SARS) and Middle East respiratory syndrome
coronavirus (MERS) outbreaks after
hospitalisation or ICU admission: a systematic
review and meta-analysis. Journal of
rehabilitation medicine, 52(5), 1-11.
Anjana, N. K. N., Annie, T. T., Siba, S.,
Meenu, M. S., Chintha, S., & Anish, T.
S. N. (2021). Manifestations and risk
factors of post COVID syndrome among
COVID-19 patients presented with
minimal symptoms–A study from Kerala,
India. Journal of Family Medicine and
Primary Care, 10(11), 4023.Malik, P., Patel, K., Pinto, C., Jaiswal, R.,
Tirupathi, R., Pillai, S., & Patel, U.
(2022). Post‐acute COVID‐19 syndrome
(PCS) and health‐related quality of life
(HRQoL)—A systematic review and meta‐
analysis. Journal of medical
virology, 94(1), 253-262.
Cortinovis, M., Perico, N., & Remuzzi, G.
(2021). Long-term follow-up of recovered
patients with COVID-19. The
Lancet, 397(10270), 173-175.
Lopez-Leon, S., Wegman-Ostrosky, T.,
Perelman, C., Sepulveda, R., Rebolledo,
P. A., Cuapio, A., & Villapol, S. (2021).
More than 50 long-term effects of
COVID-19: a systematic review and metaanalysis. Scientific reports, 11(1), 1-12.
Moreno-Pérez, O., Merino, E., LeonRamirez, J. M., Andres, M., Ramos, J.
M., Arenas-Jiménez, J., ... & COVID19-
ALC research group. (2021). Post-acute
COVID-19 syndrome. Incidence and risk
factors: A Mediterranean cohort
study. Journal of Infection, 82(3), 378-
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T.
A., McGuire, P., Fusar-Poli, P., ... & David,
A. S. (2020). Psychiatric and neuropsychiatric
presentations associated with severe
coronavirus infections: a systematic review and
meta-analysis with comparison to the COVID-
pandemic. The Lancet Psychiatry, 7(7),
-627.
van Kessel, S. A., Olde Hartman, T. C.,
Lucassen, P. L., & van Jaarsveld, C. H.
(2022). Post-acute and long-COVID-19
symptoms in patients with mild diseases: a
systematic review. Family practice, 39(1),
-167.
Yousif, I. I., Hashim, A. R., & Farid, H. A.
(2021). The clinical manifestation of post
COVID-19 syndrome among Basra city
population-southern of Iraq. Annals of the
Romanian Society for Cell Biology, 5867-
Peghin, M., Palese, A., Venturini, M., De
Martino, M., Gerussi, V., Graziano, E., ...
& Tascini, C. (2021). Post-COVID-19
symptoms 6 months after acute infection
among hospitalized and non-hospitalized
patients. Clinical Microbiology and
Infection, 27(10), 1507-1513.
Garout, M. A., Saleh, S. A., Adly, H. M.,
Abdulkhaliq, A. A., Khafagy, A. A.,
Abdeltawab, M. R., ... & Alandiyjany, M.
N. (2022). Post‐COVID-19 syndrome:
assessment of short-and long-term postrecovery symptoms in recovered cases in
Saudi Arabia. Infection, 1-9.
Ayoubkhani, D., Khunti, K., Nafilyan, V.,
Maddox, T., Humberstone, B., Diamond,
I., & Banerjee, A. (2021). Post-covid
syndrome in individuals admitted to
hospital with covid-19: retrospective
cohort study. BMJ 372: n693.
Cochran WG. Sampling techniques. 3rd ed.
New Jersey: Wiley; 2007.
Fernández-de-Las-Peñas, C., Martín-Guerrero,
J. D., Pellicer-Valero, Ó. J., Navarro-Pardo,
E., Gómez-Mayordomo, V., Cuadrado, M.
L., ... & Arendt-Nielsen, L. (2022). Female
sex is a risk factor associated with long-term
post-COVID related-symptoms but not with
COVID-19 symptoms: The LONG-COVIDEXP-CM multicenter study. Journal of
clinical medicine, 11(2), 413.
Gebhard, C., Regitz-Zagrosek, V.,
Neuhauser, H. K., Morgan, R., & Klein,
S. L. (2020). Impact of sex and gender on
COVID-19 outcomes in Europe. Biology
of sex differences, 11(1), 1-13.
Carvalho-Schneider, C., Laurent, E., Lemaignen,
A., Beaufils, E., Bourbao-Tournois, C.,
Laribi, S., ... & Bernard, L. (2021). Follow-up
of adults with noncritical COVID-19 two
months after symptom onset. Clinical
Microbiology and Infection, 27(2), 258-263.
Kamal, M., Abo Omirah, M., Hussein, A., &
Saeed, H. (2021). Assessment and
characterisation of post‐COVID‐19
manifestations. International journal of
clinical practice, 75(3), e13746.
Hussein, A. A. M., Saad, M., Zayan, H. E.,
Abdelsayed, M., Moustafa, M., Ezzat, A. R., ...
& Sayed, I. (2021). Post-COVID-19 functional
status: Relation to age, smoking, hospitalization,
and previous comorbidities. Annals of Thoracic
Medicine, 16(3), 260.
Asadi-Pooya, A. A., Akbari, A., Emami, A.,
Lotfi, M., Rostamihosseinkhani, M.,
Nemati, H., ... & Shahisavandi, M. (2021).
Risk factors associated with long COVID
syndrome: a retrospective study. Iranian
Journal of Medical Sciences, 46(6), 428Zhou, F., Tao, M., Shang, L., Liu, Y., Pan,
G., Jin, Y., ... & Yang, S. (2021).
Assessment of sequelae of COVID-19
nearly 1 year after diagnosis. Frontiers in
Medicine, 8.
Seeßle, J., Waterboer, T., Hippchen, T.,
Simon, J., Kirchner, M., Lim, A., ... &
Merle, U. (2022). Persistent symptoms in
adult patients 1 year after coronavirus
disease 2019 (COVID-19): a prospective
cohort study. Clinical infectious
diseases, 74(7), 1191-1198.
Algahtani, F. D., Hassan, S. U. N., Alsaif, B.,
& Zrieq, R. (2021). Assessment of the
quality of life during COVID-19
pandemic: a cross-sectional survey from
the Kingdom of Saudi
Arabia. International journal of
environmental research and public
health, 18(3), 847.
Förster, C., Colombo, M. G., Wetzel, A. J.,
Martus, P., & Joos, S. (2022). Persisting
Symptoms After COVID-19. Deutsches
Aerzteblatt International, 119(10).
Jassat, W., Mudara, C., Vika, C., Welch, R.,
Arendse, T., Dryden, M. T. G., ... &
Cohen, C. (2022). A cohort study of Post
COVID-19 Condition across the Beta,
Delta and Omicron waves in South
Africa: 6-month follow up of hospitalised
and non-hospitalised
participants. medRxiv.
Tosato, M., Carfì, A., Martis, I., Pais, C.,
Ciciarello, F., Rota, E., ... & Team, P. A.
C. (2021). Prevalence and predictors of
persistence of COVID-19 symptoms in
older adults: a single-center study. Journal
of the American Medical Directors
Association, 22(9), 1840-1844.
Jacobs, L. G., Gourna Paleoudis, E., LeskyDi Bari, D., Nyirenda, T., Friedman, T.,
Gupta, A., ... & Aschner, J. L. (2020).
Persistence of symptoms and quality of life
at 35 days after hospitalization for
COVID-19 infection. PloS one, 15(12),
e0243882.
Carfì, A., Bernabei, R., Landi, F., & Gemelli
Against COVID-19 Post-Acute Care
Study Group (2020). Persistent Symptoms
in Patients After Acute COVID-
JAMA, 324(6), 603–605.
https://doi.org/10.1001/jama.2020.12603
Daher, A., Balfanz, P., Cornelissen, C.,
Müller, A., Bergs, I., Marx, N., ... &
Müller, T. (2020). Follow up of patients
with severe coronavirus disease 2019
(COVID-19): Pulmonary and
extrapulmonary disease
sequelae. Respiratory medicine, 174,
Nguyen, N. N., Hoang, V. T., Dao, T. L.,
Dudouet, P., Eldin, C., & Gautret, P.
(2022). Clinical patterns of somatic
symptoms in patients suffering from postacute long COVID: a systematic
review. European Journal of Clinical
Microbiology & Infectious Diseases, 1-31.
Iqbal, A., Iqbal, K., Ali, S. A., Azim, D.,
Farid, E., Baig, M. D., ... & Raza, M.
(2021). The COVID-19 sequelae: a crosssectional evaluation of post-recovery
symptoms and the need for rehabilitation
of COVID-19 survivors. Cureus, 13(2).
Larijani, M. S., Ashrafian, F., Amiri, F. B.,
Banifazl, M., Bavand, A., Karami, A., ...
& Ramezani, A. (2022). Characterization
of long COVID-19 manifestations and its
associated factors: A prospective cohort
study from Iran. Microbial Pathogenesis,
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
